Plasma therapy or convalescent plasma therapy is one of the most popular and constructive methods to boost the immune system. It involves use of blood from a person who has recently recovered from an illness to donate it to someone who is currently suffering from the same disease. This blood is likely to contain antibodies that are essential to fight the illness, especially when the patient’s immune system is not positively responding.
According to Allied Market Research, the global plasma therapy market is projected to reach $698.46 million by 2030,
registering a CAGR of 8.5% from 2021 to 2030. The surge in the geriatric
population and prevalence of rare diseases, the rise in the number of
androgenic alopecia patients, and increase in the number of plasma collection
centers drive the growth of the market.
The use of plasma therapy has proven to be effective for back pain and
dermatological treatment. As this method of treatment is considered to be much
safer, the use of plasma therapy for orthopedic illnesses and skin diseases has
increased drastically. The therapy is less painful, causes less thermal damage
and bleeding during the process, and improves the recovery period considerably.
More importantly, it poses no risk of transurethral resection (TUR) syndrome
and other side effects.
Platelet-rich plasma (PRP) therapy gained traction for dealing with skin
diseases. The treatment gained popularity as a “vampire facial” as it used
plasma from other patients to stimulate skin regeneration. People who are more
concerned about injecting foreign chemicals into their bodies prefer to undergo
plasma therapy, especially treating hair regeneration and acne scarring. What’s
more, PRP therapy can stimulate hair growth cells and help gain thicker hair
over time.
Apart from the treatment of skin diseases, plasma therapy to treatment of
the orthopedic condition is considered to be one of the rapidly-evolving
branches of science. Several clinical results show that PRP is a more promising
method to treat soft tissues and bone-related injuries compared to traditional
methods. Now, plasma therapy is recommended to treat various conditions such as
rotator cuff injury, Achilles tendinopathy, and lateral epicondylitis.
For Right Perspective and Competitive Insights, Get Sample
Report at: https://www.alliedmarketresearch.com/request-sample/14049
Impact of COVID-19 Pandemic
on the Plasma Therapy Market
Plasma
from the blood of a patient who recovered from the COVID-19 was used for
treatment of another patient suffering from COVID-19. Convalescent plasma can
potentially develop as an effective treatment option to battle against the
pandemic. Thus, rise in demand for plasma derived immunoglobulins for treatment
procedures for COVID-19 patients with autoimmune and inflammatory disorders,
which is anticipated to drive growth of the plasma fractionation market for
immunoglobulin.
Plasma therapy is used for treatment of many disorders such
as hair loss, tendon injuries, acute injuries, post-surgical repair, and
osteoarthritis and currently for treatment of COVID–19. Furthermore, several
manufacturers are initiating plasma processing to tackle the spread of
coronavirus across the world. Therefore, the global plasma therapy market is
expected to witness significant growth during the forecast period.
During the Covid-19 outbreak, plasma
therapy was used. Until researchers could find a vaccine or proper method of
treatment for a novel viral infection, plasma therapy offers the best chance to
fight the disease. However, plasma therapy still needs the support of clinical
trials for its widespread use, they have proven to be effective in treating
chronic illness. Thus, in the future, more companies would invest in clinical trials
and make it an ideal method of treatment for fighting novel infections or
outbreaks.
0 Comments